Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of California, San Francisco
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center